Home Stock

Stock Research: Gilead

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Gilead

NSQ:GILD US3755581036
83
  • Value
    81
  • Growth
    77
  • Safety
    Safety
    36
  • Combined
    63
  • Sentiment
    55
  • 360° View
    360° View
    83
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Gilead Sciences, Inc. is a biopharmaceutical company focused on medicines for life-threatening diseases. It operates in the biopharmaceutical industry, with marketed products including Biktarvy and others. The company operates in more than 35 countries worldwide. In the last fiscal year, the company had a market cap of $135,066 million, profits of $22,503 million, revenue of $28,754 million, and 17,600 employees.

more
Strongest Rank Leverage
Weakest Rank Dividend Yield
Country USA
Industry Biotechnology
Size XX-Large
Website gilead.com
Index
NASDAQ 100
NASDAQ
D.J. US Health Care
S&P 500
Gilead stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
81 67 n/a n/a
Growth
77 63 n/a n/a
Safety
Safety
36 70 n/a n/a
Sentiment
55 98 n/a n/a
360° View
360° View
83 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
33 43 n/a n/a
Opinions Change
18 86 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
82 79 n/a n/a
Sentiment
55 98 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
81 67 n/a n/a
Growth
77 63 n/a n/a
Safety Safety
36 70 n/a n/a
Combined
63 86 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
59 28 n/a n/a
Price vs. Earnings (P/E)
64 57 n/a n/a
Price vs. Book (P/B)
10 16 n/a n/a
Dividend Yield
100 98 n/a n/a
Value
81 67 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
39 26 n/a n/a
Profit Growth
96 84 n/a n/a
Capital Growth
40 33 n/a n/a
Stock Returns
61 83 n/a n/a
Growth
77 63 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
5 64 n/a n/a
Refinancing
9 24 n/a n/a
Liquidity
91 89 n/a n/a
Safety Safety
36 70 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Gilead and broaden your portfolio horizons.

Salesforce

NYQ:CRM
Country: USA
Industry: Application Software
Size: XX-Large
Full Stock Analysis

Micron

NSQ:MU
Country: USA
Industry: Semiconductors
Size: XX-Large
Full Stock Analysis

Walt Disney

NYQ:DIS
Country: USA
Industry: Movies & Entertainment
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews